Results 151 to 160 of about 57,216 (335)

Amlodipine associated hyperpigmentation

open access: yesSaudi Medical Journal, 2004
Amlodipine is a potent peripheral and coronary vasodilator with high selectivity for vascular smooth muscle, and is widely used in mild to moderate hypertension, chronic stable angina and vasospastic angina. Its most prevalent side effects are peripheral edema, flushing and headache.
openaire   +2 more sources

Novel Histopathologic Features of Diffuse Blue‐Gray Hyperpigmentation Associated With Kratom Use: A Case Report and Literature Review

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Drug‐induced hyperpigmentation accounts for 10%–20% of acquired pigmentary disorders and can be misdiagnosed for other causes such as melasma, post inflammatory changes, or heavy metal deposition. Kratom (Mitragyna speciosa), a Southeast Asian plant with an opioid‐like profile, has been increasingly used in the United States for ...
Rita Kamoua   +4 more
wiley   +1 more source

Discoid Lupus Erythematosus in Genital Skin: A Case Report and Review of the Literature

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Discoid lupus erythematosus (DLE) represents the most common variant of chronic cutaneous lupus erythematosus, a skin‐specific autoimmune disorder within the broader lupus erythematosus spectrum Clinically, DLE is characterized by erythematous, scaly plaques with areas of hyperpigmentation.
Ala' Abu‐Dayeh   +2 more
wiley   +1 more source

PATHOPHYSIOLOGICAL INSIGHTS INTO FACIAL HYPERPIGMENTATION AND AESTHETIC TREATMENT MODALITIES

open access: yesAnti-Aging Eastern Europe
Facial hyperpigmentation, including melasma and post-inflammatory hyperpigmentation, poses a significant dermatological and psychosocial challenge. These conditions arise from a complex interplay of genetic factors, hormonal influences, and environmental
Yuliya Fedorchenko
doaj   +1 more source

National Delphi consensus on laser and energy‐based treatments for rosacea

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Various treatments are available for rosacea, including lasers and energy‐based devices (EBDs). However, the specific role of lasers and EBDs in rosacea management remains insufficiently defined in Germany. The aim of the study was to develop a comprehensive expert consensus on the use of lasers and EBDs in the treatment of rosacea ...
Lynhda Nguyen   +16 more
wiley   +1 more source

Facial hyperpigmentation: Any link to cancer?

open access: yes, 2018
Introduction: Ectopic adrenocorticotropic hormone (ACTH) syndrome is recognized by edema, proximal muscle weakness, hypertension, diabetes and skin hyperpigmentation. This syndrome is mainly associated with malignancies. Case presentation: A 43-
Abaszadeh, Mahsa   +3 more
core   +1 more source

Combined use of oral and topical forms of phlebotonics after endovasal laser coagulation

open access: yesАмбулаторная хирургия
Introduction. The combination of endovasal laser coagulation and miniphlebectomy is actively used in the treatment of Chronic venous diseases, however, the question of improving the management of such patients in the postoperative period remains actual ...
Yu. M. Chubirko, I. O. Kasyanov
doaj   +1 more source

Extensive hyperpigmentation during pregnancy: a case report

open access: yes, 2011
Introduction Skin hyperpigmentation is common during pregnancy and often is due to endocrinological changes. Usual patterns include linea nigra, darkening of areola and melasma. We report a rare diffused hyperpigmentation condition in a pregnant woman of
Magoma Moke   +5 more
core   +1 more source

Treatments for Molluscum contagiosum: A systematic review

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Molluscum contagiosum (MC) is a viral skin infection that poses significant physical and psychosocial burdens, particularly in pediatric and immunocompromised populations. Despite the availability of various treatment options, comparative efficacy and safety data remain limited.
Ou Jia (Emilie) Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy